Financhill
Back

Regeneron Pharmaceuticals Vs. Biogen Industry Stock Comparison

Sell
45

REGN
Regeneron Pharmaceuticals

Last Price:
$716.20
Seasonality Move:
9.99%
Sell
39

BIIB
Biogen

Last Price:
$149.95
Seasonality Move:
3.15%
Sell
45
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $714.47. The Score for REGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $149.02. The Score for BIIB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $714.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $149.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -28.29 Sell
Relative Strength Index (14 RSI): 33.65 Sell
Chaikin Money Flow: 76976 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (722.36 - 767.32) Sell
Bollinger Bands (100): (794.69 - 1135.85) Sell

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.19 Sell
Relative Strength Index (14 RSI): 32.44 Sell
Chaikin Money Flow: 349631 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (150.37 - 160.27) Sell
Bollinger Bands (100): (163.23 - 201.35) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 718.81 Sell
20-day SMA: 745.06 Sell
50-day SMA: 814.52 Sell
200-day SMA: 978.35 Sell
8-day EMA: 721.7 Sell
20-day EMA: 744.32 Sell
50-day EMA: 815.43 Sell
200-day EMA: 930.06 Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 148.78 Buy
20-day SMA: 154.85 Sell
50-day SMA: 166.45 Sell
200-day SMA: 200.8 Sell
8-day EMA: 149.75 Sell
20-day EMA: 154.14 Sell
50-day EMA: 165.03 Sell
200-day EMA: 197.19 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.14 per share.

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.12 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):